Drug: TYSABRI Injury: Hypersensitivity Quarter: 2016Q3
Total Records: 37 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 118897767 | TYSABRI | Hypersensitivity | BIOGEN | 33.00 YR | F | 85 KG | 20160708 | CO |
| 120128822 | TYSABRI | Hypersensitivity | BIOGEN | 56.28 YR | F | 0 | 20160829 | US |
| 120134742 | TYSABRI | Hypersensitivity | BIOGEN | 48.39 YR | F | 0 | 20160811 | CA |
| 120561775 | TYSABRI | Hypersensitivity | BIOGEN | 64.28 YR | M | 0 | 20160907 | US |
| 121715984 | TYSABRI | Hypersensitivity | BIOGEN | 26.70 YR | F | 75 KG | 20160812 | CO |
| 123822933 | TYSABRI | Hypersensitivity | BIOGEN | 47.45 YR | M | 0 | 20160708 | BR |
| 124180962 | TYSABRI | Hypersensitivity | BIOGEN | 0.00 | F | 0 | 20160721 | US |
| 124409092 | TYSABRI | Hypersensitivity | BIOGEN | 46.12 YR | F | 74 KG | 20160705 | JP |
| 124582026 | TYSABRI | Hypersensitivity | BIOGEN | 31.28 YR | F | 0 | 20160802 | US |
| 124742862 | TYSABRI | Hypersensitivity | BIOGEN | 0.00 | F | 0 | 20160715 | US |
| 125025852 | TYSABRI | Hypersensitivity | BIOGEN | 37.96 YR | F | 0 | 20160729 | US |
| 125089562 | TYSABRI | Hypersensitivity | BIOGEN | 58.26 YR | F | 0 | 20160824 | US |
| 125282781 | TYSABRI | Hypersensitivity | BIOGEN | 23.48 YR | F | 0 | 20160705 | CA |
| 125349062 | TYSABRI | Hypersensitivity | BIOGEN | 0.00 | F | 0 | 20160804 | US |
| 125547491 | TYSABRI | Hypersensitivity | BIOGEN | 42.14 YR | F | 0 | 20160713 | IT |
| 125583883 | TYSABRI | Hypersensitivity | BIOGEN | 46.34 YR | F | 0 | 20160810 | US |
| 125685531 | TYSABRI | Hypersensitivity | BIOGEN | 63.12 YR | F | 0 | 20160719 | US |
| 125792681 | TYSABRI | Hypersensitivity | BIOGEN | 0.00 | F | 0 | 20160721 | US |
| 125854631 | TYSABRI | Hypersensitivity | BIOGEN | 63.58 YR | F | 0 | 20160724 | US |
| 126066531 | TYSABRI | Hypersensitivity | BIOGEN | 0.00 | F | 0 | 20160729 | US |
Total Records: 37 Number of Pages: 2